Additionally, it addresses the FDA’s communications While using the applicant, the retention of records that assistance the SE report, confidentiality of the SE report, how an applicant can amend or withdraw an SE report, how an applicant may possibly transfer ownership of the SE report to a new applicant and Digital submission on the SE report a